RUSSEL LANDRY: Open Payments
NPI 1629757232 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 8 companies in 2025. Trend: 2023 $47 · 2024 $256 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $53 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $26 |
| Seqirus USA Inc | 1 | $26 |
| Antares Pharma, Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: INJECTAFER, WATCHMAN FLX, Fluad, QULIPTA, XYOSTED, CREON, NURTEC ODT, VRAYLAR.
Industry payments across LA — which companies pay providers there.
